Review



panobinostat clinical trial  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Thermo Fisher panobinostat clinical trial
    Detection of MS RNA is associated with detection of plasma HIV RNA following administration of the HDACi <t>panobinostat</t> to PLWH on ART. (a) US, MS, and plasma HIV were measured and the percentage of participants positive for each RNA measure are shown for timepoints prior to panobinostat and ( b ) on panobinostat treatment. ( c ) The proportion of participants with a positive plasma HIV RNA according to the amount of MS RNA. ( d ) Amount of MS RNA in samples collected at time points prior to and following panobinostat where plasma HIV RNA was detected or not . For d, data are shown as median +/- IQR. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001 .
    Panobinostat Clinical Trial, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/panobinostat+clinical+trial/PANOBINOSTAT/pmc07920823-79-3-22
    Average 94 stars, based on 1 article reviews
    panobinostat clinical trial - by Bioz Stars, 2026-09
    94/100 stars

    Images

    1) Product Images from "Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency"

    Article Title: Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency

    Journal: EBioMedicine

    doi: 10.1016/j.ebiom.2021.103241

    Detection of MS RNA is associated with detection of plasma HIV RNA following administration of the HDACi panobinostat to PLWH on ART. (a) US, MS, and plasma HIV were measured and the percentage of participants positive for each RNA measure are shown for timepoints prior to panobinostat and ( b ) on panobinostat treatment. ( c ) The proportion of participants with a positive plasma HIV RNA according to the amount of MS RNA. ( d ) Amount of MS RNA in samples collected at time points prior to and following panobinostat where plasma HIV RNA was detected or not . For d, data are shown as median +/- IQR. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001 .
    Figure Legend Snippet: Detection of MS RNA is associated with detection of plasma HIV RNA following administration of the HDACi panobinostat to PLWH on ART. (a) US, MS, and plasma HIV were measured and the percentage of participants positive for each RNA measure are shown for timepoints prior to panobinostat and ( b ) on panobinostat treatment. ( c ) The proportion of participants with a positive plasma HIV RNA according to the amount of MS RNA. ( d ) Amount of MS RNA in samples collected at time points prior to and following panobinostat where plasma HIV RNA was detected or not . For d, data are shown as median +/- IQR. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001 .

    Techniques Used: Clinical Proteomics

    Correlation between SN RNA and either US or MS RNA 3 days post-stimulation with LRAs. ( a ) Spearman correlation coefficients and 95% confidence intervals are shown for comparisons between SN RNA and US or MS RNA in total and resting CD4+ T cells after adjustment for repeated measures from the same donor using raw and fold change data following stimulation with LRAs. ( b ) Scatter plots are shown for the fold change from DMSO and the raw values of each parameter quantified in total (closed) and resting (open) CD4+ T cells. The Spearman correlation coefficients (r) and p values after controlling for multiple observations per donor are shown. Each donor is shown as a different symbol and each LRA a different color. Gray = DMSO, blue = vorinostat, purple = romidepsin, green = panobinostat, orange = JQ1, PMA+PHA = red. * p < 0.05; ** p < 0.01; *** p < 0.001, **** p < 0.0001.
    Figure Legend Snippet: Correlation between SN RNA and either US or MS RNA 3 days post-stimulation with LRAs. ( a ) Spearman correlation coefficients and 95% confidence intervals are shown for comparisons between SN RNA and US or MS RNA in total and resting CD4+ T cells after adjustment for repeated measures from the same donor using raw and fold change data following stimulation with LRAs. ( b ) Scatter plots are shown for the fold change from DMSO and the raw values of each parameter quantified in total (closed) and resting (open) CD4+ T cells. The Spearman correlation coefficients (r) and p values after controlling for multiple observations per donor are shown. Each donor is shown as a different symbol and each LRA a different color. Gray = DMSO, blue = vorinostat, purple = romidepsin, green = panobinostat, orange = JQ1, PMA+PHA = red. * p < 0.05; ** p < 0.01; *** p < 0.001, **** p < 0.0001.

    Techniques Used:

    Related Articles

    Gene Expression:

    Article Title: Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency
    Article Snippet: For ex vivo HIV RNA data, HIV RNA was normalized per RNA input, measured by NanoDrop (ThermoFisher), and presented as copies per 500 ng RNA. .. For the prospective panobinostat clinical trial, HIV RNA was normalized to the 18s housekeeping gene using the 18s Taqman gene Expression Assay (Life Technologies, cat # 4331182) and HIV RNA is presented as copies per 10^6 18s copies, as previously described. ..



    Similar Products

    panobinostat clinical trial  (Thermo Fisher)
    94
    Thermo Fisher panobinostat clinical trial
    Detection of MS RNA is associated with detection of plasma HIV RNA following administration of the HDACi <t>panobinostat</t> to PLWH on ART. (a) US, MS, and plasma HIV were measured and the percentage of participants positive for each RNA measure are shown for timepoints prior to panobinostat and ( b ) on panobinostat treatment. ( c ) The proportion of participants with a positive plasma HIV RNA according to the amount of MS RNA. ( d ) Amount of MS RNA in samples collected at time points prior to and following panobinostat where plasma HIV RNA was detected or not . For d, data are shown as median +/- IQR. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001 .
    Panobinostat Clinical Trial, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/panobinostat+clinical+trial/PANOBINOSTAT/pmc07920823-79-3-22
    Average 94 stars, based on 1 article reviews
    panobinostat clinical trial - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Detection of MS RNA is associated with detection of plasma HIV RNA following administration of the HDACi panobinostat to PLWH on ART. (a) US, MS, and plasma HIV were measured and the percentage of participants positive for each RNA measure are shown for timepoints prior to panobinostat and ( b ) on panobinostat treatment. ( c ) The proportion of participants with a positive plasma HIV RNA according to the amount of MS RNA. ( d ) Amount of MS RNA in samples collected at time points prior to and following panobinostat where plasma HIV RNA was detected or not . For d, data are shown as median +/- IQR. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001 .

    Journal: EBioMedicine

    Article Title: Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency

    doi: 10.1016/j.ebiom.2021.103241

    Figure Lengend Snippet: Detection of MS RNA is associated with detection of plasma HIV RNA following administration of the HDACi panobinostat to PLWH on ART. (a) US, MS, and plasma HIV were measured and the percentage of participants positive for each RNA measure are shown for timepoints prior to panobinostat and ( b ) on panobinostat treatment. ( c ) The proportion of participants with a positive plasma HIV RNA according to the amount of MS RNA. ( d ) Amount of MS RNA in samples collected at time points prior to and following panobinostat where plasma HIV RNA was detected or not . For d, data are shown as median +/- IQR. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001 .

    Article Snippet: For the prospective panobinostat clinical trial, HIV RNA was normalized to the 18s housekeeping gene using the 18s Taqman gene Expression Assay (Life Technologies, cat # 4331182) and HIV RNA is presented as copies per 10^6 18s copies, as previously described.

    Techniques: Clinical Proteomics

    Correlation between SN RNA and either US or MS RNA 3 days post-stimulation with LRAs. ( a ) Spearman correlation coefficients and 95% confidence intervals are shown for comparisons between SN RNA and US or MS RNA in total and resting CD4+ T cells after adjustment for repeated measures from the same donor using raw and fold change data following stimulation with LRAs. ( b ) Scatter plots are shown for the fold change from DMSO and the raw values of each parameter quantified in total (closed) and resting (open) CD4+ T cells. The Spearman correlation coefficients (r) and p values after controlling for multiple observations per donor are shown. Each donor is shown as a different symbol and each LRA a different color. Gray = DMSO, blue = vorinostat, purple = romidepsin, green = panobinostat, orange = JQ1, PMA+PHA = red. * p < 0.05; ** p < 0.01; *** p < 0.001, **** p < 0.0001.

    Journal: EBioMedicine

    Article Title: Multiply spliced HIV RNA is a predictive measure of virus production ex vivo and in vivo following reversal of HIV latency

    doi: 10.1016/j.ebiom.2021.103241

    Figure Lengend Snippet: Correlation between SN RNA and either US or MS RNA 3 days post-stimulation with LRAs. ( a ) Spearman correlation coefficients and 95% confidence intervals are shown for comparisons between SN RNA and US or MS RNA in total and resting CD4+ T cells after adjustment for repeated measures from the same donor using raw and fold change data following stimulation with LRAs. ( b ) Scatter plots are shown for the fold change from DMSO and the raw values of each parameter quantified in total (closed) and resting (open) CD4+ T cells. The Spearman correlation coefficients (r) and p values after controlling for multiple observations per donor are shown. Each donor is shown as a different symbol and each LRA a different color. Gray = DMSO, blue = vorinostat, purple = romidepsin, green = panobinostat, orange = JQ1, PMA+PHA = red. * p < 0.05; ** p < 0.01; *** p < 0.001, **** p < 0.0001.

    Article Snippet: For the prospective panobinostat clinical trial, HIV RNA was normalized to the 18s housekeeping gene using the 18s Taqman gene Expression Assay (Life Technologies, cat # 4331182) and HIV RNA is presented as copies per 10^6 18s copies, as previously described.

    Techniques: